Navigation Links
Gene Therapy May Help Restore Sight In Congenital blindness

Researchers from the University of Florida announced on Monday that they have given sight to baby chickens with a disease that otherwise would have left them blind// by using a gene therapy.

The researchers hope that the gene therapy may one day prevent a hereditary form of childhood blindness after they had achieved a promising study on chickens with the same condition. They explained that the research, which delayed the onset of blindness in chickens, might one day protect children from becoming blind due to an inherited disease called Leber congenital amaurosis (LCA).

Susan Semple-Rowland at the University of Florida in Gainesville, Florida, US, who led the study, explained that the chickens with the disease are normally born blind. And she further explained that six out of seven chickens that had undergone the gene therapy technique while still in the egg hatched out with sight.

She and her colleagues focused their study on mutations in the GUCY2D gene, which is responsible for LCA1 the most common type of LCA, accounting for up to 20% of cases of blindness. They explained that in people who carry two faulty GUCY2D genes, the cells at the back of the eye are unable to respond properly to light, and therefore cannot send proper visual signals to the brain. They also said that the individuals who suffer from this disorder typically become blind in infancy.

The scientists explained that they used a virus containing a normal copy of the defective photoreceptor gene and injected it through an eggshell into the developing chicken embryo. Rowland said that after the first treated chick had hatched, it began to peck at little dots on a piece of paper. The scientists have however noted that the procedure had slowed the degeneration of the chicks' photoreceptors, but it did not completely halt it.

‘The visual capabilities of the treated animals far exceeded our expectations’, said Rowland, about their study that
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis

Post Your Comments:
(Date:12/4/2009)... , , WASHINGTON, Dec. 4 /PRNewswire-USNe...h care overhaul plan, Family Research Council (FRC...ll household phones in Louisiana to survey each ho...ll. These include abortion funding, rationing, hi... public option. Survey participants who express o...
(Date:12/4/2009)... , , PACIFIC PALISADES, Calif., Dec. 4 /P...ason and give your loved ones something they can b...ith Dermagenics® Physician-Formulated Anti-Wr...timate youthful appearance made possible with an a...ed. ,, Dermagenics Ultra-Intensive Anti-Wrinkle...
(Date:12/4/2009)... Social network profile usually conveys true pers...(HealthDay News) -- Does your profile on an online... you? The odds are good that it does, reports a ne...heir true selves instead of idealized identities. ... widely held assumption is that people are using t...
(Date:12/4/2009)... , , BATESVILLE, Ind., Dec. 4 /PRNewswire...C ) today announced its fiscal 2010 first quarter ...eclared by Hill-Rom,s Board of Directors on Decemb...o shareholders of record as of December 17, 2009. ...ill-Rom is a leading worldwide manufacturer and pr...
(Date:12/4/2009)... , , UNION, N.J., Dec. 4 /PRNewswire/ -...xpanded its specialty anatomic pathology services ...offering. The new service completes the company,s ...national anatomic pathology company offering diagn...including gastroenterology, urology and now hemato...
Breaking Medicine News(10 mins):Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2Health News:Give the Gift of Beautiful Skin for the Holiday Season 2Health News:Online Identities Likely to Match Reality 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3
...es PDL,s Queen et al. Patents for Soliris(R) , ,...5 PDL BioPharma, Inc. (Nasdaq: PDLI ) and Alex... jointly announced that the companies have entered...oliris(R) (eculizumab) and PDL,s patents known as ...
... Jan. 5 The Ensign Group, Inc. (Nasdaq: ENSG ),...althcare Center, a 150-bed skilled nursing facilit...uary 1, 2009. The facility has been renamed Southl...ition, and adds to our growing critical mass in th...
...O, Calif., Jan. 5 The Ensign Group, Inc. (Nasdaq:...brillo Care Center, a 156-bed skilled nursing faci...was effective January 1, 2009. The facility has be...o extend our growing footprint into California,s C...
... LFC Group of Companies Announces Newest... Colorado , Newport Beach...real estate auction marketing firm, LFC Group of C...E.com/284R3 ). The auction, a builder closeout of ...
... Help us, help the Red Cross meet the wi...n our new Hyundai Dealer showroom at 271 Main St. ...ou,re one of the first 50 to donate blood. , ...he recent ice & snow storms that hit New Engla...
... A proven and widely adopted research in...milestone this fall with the implementation at a w.... At the end of September, the University of Wisco...n needs. OnCore is the flagship product of PercipE...
Other Medicine News:Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2Health News:The Ensign Group Acquires California Skilled Nursing Facility 2Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 2Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 3Health News:Let the Bidding Begin in Online Auction of Denver Luxury Homes 4Health News:Boston Hyundai Dealer Teams up With the Red Cross to Save Lives 2Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 2Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 3Health News:OnCore System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research 4
(Date:12/4/2009)... ,, WASHINGTON, Dec. 4 /PRNewswire-US...d a new report published by the Pharmaceutical ...hat identifies 97 new drugs and vaccines in develo..., The report found that the 97 products in devel...e drugs are either in human clinical trials or awa...
(Date:12/4/2009)... , BILLERICA, Mass., Dec. 4 /PRNewswire-First...subsidiary of Volcano Corporation (Nasdaq: VOLC )...essful testing of a novel integrated light source ... proprietary optical engine design raises the bar ...ions of laser-based designs for swept source OCT l...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 ...ompany") (OTC Bulletin Board: NWBO) announced toda...wed its patent application on a system for automat...e Company,s DCVax® therapeutic cancer vaccine...the very high concentration of dendritic cells (wh...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Press Ganey Announces Opening of Boston Office 50837 1Press Ganey Announces Opening of Boston Office 50837 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 1Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 3Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 1Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 2Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients 9127 3
...cs, Inc. (OTC Bulletin Board: CVBT) has entered in...e the sponsor and general,partner of ProDerm Limit...,$1 million and up to $10 million of the clinical ...e., "I am extremely impressed with CVBT,s wound h...treat patients for diabetic ulcers and venous,stas...
...on Study Demonstrates an Improvement in De..., Calif., May 22 CNS Response, Inc.,(OTC Bulletin...y presented,at the American Psychiatric Associatio...tt, M.D., Chief Medical Officer, Walden Behavioral...grams. The poster presentation,titled "Referenced-...
Other Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 2CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 5CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 6
...imaging and an extraordinary combination of featur...pecialty clinical environment. The versatility and...are allows you to perform a wide variety of exams ...eal choice for multiple imaging modalities, the SS...
Anti HTLV -I/HTLV -II
...currently developing additional assays for the blo...3.47 million to date in contract funding from the ...as been used to develop the Procleix WNV Assay. Th...centers under an Investigational New Drug Applicat...
Anti-HBc: CORE Test
Medicine Products: